effect of Unani formulation in Diabetic patients
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/07/055902
- Lead Sponsor
- Central Council for Research in Unani Medicine(CCRUM)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of any sex aged of 30-65 years.
Fasting plasma glucose levels between 126 and 175 mg/dL (or)
Post Prandial plasma glucose levels between 200 and 250 mg/dL (or)
HbA1c level between 6.5 and 8% (as per ADA 2010 Criteria)
Presence of any of the following symptoms and signs of diabetes mellitus: Polydipsia, Polyuria, Nocturia, Giddiness, Fatigue, Loss of Weight, Polyphagia & Loss of Libido
Subjects with FPG level >175 mg/dL and/ or PP plasma glucose level >250 mg/dL and/ or HbA1c >8%
Subjects on Insulin therapy.
Type 2 DM with complications/ Type 1 DM
Significant pulmonary/ cardiovascular/ hepato-renal dysfunction
Known cases of immune-compromised states (HIV/ AIDS, etc.)/ Malignancies
Obese subjects (BMI >30)
Pregnant and lactating women
Drug addicts/ Alcoholics
Patient not willing to attend treatment schedule regularly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method